These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15661507)
21. Melt extruded helical waxy matrices as a new sustained drug delivery system. Hasa D; Perissutti B; Grassi M; Zacchigna M; Pagotto M; Lenaz D; Kleinebudde P; Voinovich D Eur J Pharm Biopharm; 2011 Nov; 79(3):592-600. PubMed ID: 21827851 [TBL] [Abstract][Full Text] [Related]
22. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers. Papadimitriou S; Bikiaris D Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245 [TBL] [Abstract][Full Text] [Related]
23. Characterization and superficial transformations on mini-matrices made of interpolymer complexes of chitosan and carboxymethylcellulose during in vitro clarithromycin release. Gómez-Burgaz M; Torrado G; Torrado S Eur J Pharm Biopharm; 2009 Sep; 73(1):130-9. PubMed ID: 19406235 [TBL] [Abstract][Full Text] [Related]
24. Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design. Lugtu-Pe JA; Ghaffari A; Chen K; Kane A; Wu XY Eur J Pharm Sci; 2018 Nov; 124():319-327. PubMed ID: 30194980 [TBL] [Abstract][Full Text] [Related]
25. Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study. Owayez AS; Abd El-Ghany GM; Abu Hashim II Chem Pharm Bull (Tokyo); 2017; 65(6):545-557. PubMed ID: 28566647 [TBL] [Abstract][Full Text] [Related]
26. Interactions of griseofulvin with cyclodextrins in solid binary systems. Veiga MD; Díaz PJ; Ahsan F J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360 [TBL] [Abstract][Full Text] [Related]
27. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194 [TBL] [Abstract][Full Text] [Related]
28. Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs. Paaver U; Heinämäki J; Laidmäe I; Lust A; Kozlova J; Sillaste E; Kirsimäe K; Veski P; Kogermann K Int J Pharm; 2015 Feb; 479(1):252-60. PubMed ID: 25549852 [TBL] [Abstract][Full Text] [Related]
29. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions. Mallick S; Sahoo A; Mitra SS Boll Chim Farm; 2003 May; 142(4):180-6. PubMed ID: 12918228 [TBL] [Abstract][Full Text] [Related]
30. Physicochemical and release properties of pellets coated with Kollicoat SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release. Dashevsky A; Wagner K; Kolter K; Bodmeier R Int J Pharm; 2005 Feb; 290(1-2):15-23. PubMed ID: 15664126 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of polyvinyl acetate dispersion as a sustained release polymer for tablets. Bordaweka MS; Zia H; Quadir A Drug Deliv; 2006; 13(2):121-31. PubMed ID: 16423800 [TBL] [Abstract][Full Text] [Related]
32. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544 [TBL] [Abstract][Full Text] [Related]
33. Polymer-mediated disruption of drug crystallinity. Rawlinson CF; Williams AC; Timmins P; Grimsey I Int J Pharm; 2007 May; 336(1):42-8. PubMed ID: 17157459 [TBL] [Abstract][Full Text] [Related]
34. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions. Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393 [TBL] [Abstract][Full Text] [Related]
35. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug. Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985 [TBL] [Abstract][Full Text] [Related]
37. Osmotic pellet system comprising osmotic core and in-process amorphized drug in polymer-surfactant layer for controlled delivery of poorly water-soluble drug. Saindane N; Vavia P J Pharm Sci; 2012 Sep; 101(9):3169-79. PubMed ID: 22418998 [TBL] [Abstract][Full Text] [Related]
39. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective. Dukeck R; Sieger P; Karmwar P Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913 [TBL] [Abstract][Full Text] [Related]
40. Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on Carbopols with isosorbite mononitrate. Efentakis M; Peponaki C AAPS PharmSciTech; 2008; 9(3):917-23. PubMed ID: 18686040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]